Skip to content

Improving consistency in regulatory assessment of repeated-dose toxicity studies: an EFSA checklist-based framework for statistical evaluation.

Sep 2026 · Regulatory toxicology and pharmacology : RTP · pp. 106249 · 0 citations · 16 references
Medicine

Abstract

The evaluation of 28- and 90-day repeated-dose toxicity studies in rodents is typically performed at the highest tier of regulatory toxicology. Despite detailed guidance from the European Food Safety Authority (EFSA) and Organisation for Economic Co-operation and Development (OECD), the practical implementation and evaluation of these studies remain challenging and may lead to variability across assessments. In risk assessment of genetically modified organisms (GMOs) intended for import into the European Union, these studies primarily provide information for evidence of adverse effects. A series of structured checklists were developed and internally applied by EFSA to support consistent, transparent, and traceable evaluations of repeated-dose toxicity studies. In this paper, we presented an application to GMO risk assessment as an illustrative example. In particular, this commentary focuses on the checklist for statistical evaluation, developed in 2019 and implemented across the European regulatory framework. This checklist translates EFSA and OECD guidance into operational criteria covering study design, experimental conduct, statistical analysis and reporting, while remaining subject to revision in response to evolving regulatory and scientific developments. We discussed the added value of the EFSA checklist and highlighted its potential to enhance consistency and robustness in regulatory decision-making. Limitations and future perspectives, including the incorporation of quantitative scoring systems and digital implementation, are also discussed.

View source

Similar papers

Open access Aug 2026

A Decision Tree for Acute Oral Toxicity: Implementing the Last Resort Requirement in Practice.

Acute oral toxicity (AOT) testing is widely used for hazard identification in chemical safety assessment, but traditional animal methods are still implemented despite their scientific limitations and ethical implications. Despite the availability of non-animal methods, regulatory uptake has been inconsistent, also due...

G. Pallocca, P. Bishop, P. Browne et al. · 0 citations
Review Sep 2026

Integration of safety pharmacology endpoints into toxicology studies - A survey of GLP institutions in China.

Integrating safety pharmacology (SP) endpoints into repeated-dose toxicology studies enables the simultaneous assessment of organ toxicity and determination of functional safety risks within a single study, a practice endorsed by regulatory guidelines. Initiated by the Chinese Safety Pharmacology Society, this question...

Bin-Rong Zhao, Chen Wang, Nao-Dan Zhang et al. · 0 citations
Review Open access Aug 2026

PFAS: challenges and scientific perspectives in human health risk assessment.

Five key recommendations for future health risk assessments are concluded, prioritizing PFAS; improving analytical methods; promoting generation of robust data and data gap filling; promoting open science, including the development of shared data infrastructure and cross-institutional knowledge exchange; and strengthen...

J. Kowalczyk, Klaus Abraham, Christina August et al. · 0 citations
Review Open access Sep 2026

Genotoxicity assessment of novel foods: insights from EFSA evaluations.

The continuous development of innovative food products has reinforced the importance of rigorous safety evaluations within the European Union (EU) novel food framework. Among toxicological endpoints, genotoxicity is a critical determinant, as substances with genotoxic potential relevant to humans raise safety concerns...

F. Rivero-Pino, Hannah Lester · 0 citations

use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans

A conceptual framework is presented for the incorporation of in vitro-derived toxicity data into the risk assessment process and the determination of a proper point-of-departure (PoD) for in vitro-in vivo extrapolation, allowing implementation in risk assessment procedures.

B. Blaauboer, K. Boekelheide, H. Clewell et al. · 0 citations
Review Open access Sep 2026

Scientific perspectives on in vivo developmental neurotoxicity testing: study design, regulatory context, and future directions.

Developmental neurotoxicity (DNT) potential of (agro)chemicals is assessed in rodents according to OECD Test Guidelines (TG) 426 (DNT) or 443 (Extended One-Generation Reproductive Toxicity; EOGRTS) incorporating a DNT cohort. While the EOGRTS evaluates reproductive and neurotoxicity endpoints across multiple life stage...

P. Coder, Richard P. Lewis, Anika Christoffel et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.